Cumberland Pharmaceuticals (CPIX) FCF Margin (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported FCF Margin of 4.24% for Q1 2026, down 2864.0% on a YoY basis from 0.15% in Q1 2025, and up 19065.65% sequentially from 0.02% in Q4 2025.
Cumberland Pharmaceuticals (CPIX) FCF Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of FCF Margin data on file, last reported at 4.24% in Q1 2026.
- For the quarter ending Q1 2026, FCF Margin fell 2864.0% year-over-year to 4.24%; the trailing twelve-month figure through Mar 2026 stood at 3.27% (down 976.0% YoY), and the FY2025 full-year result was 10.86%, up 1265.0% from the prior year.
- FCF Margin climbed to 4.24% in Q1 2026, from 0.02% in the prior quarter.
- In the past five years, FCF Margin ranged from a high of 47.42% in Q2 2023 to a low of 25.63% in Q1 2024.
- A 5-year average of 10.14% and a median of 7.54% in 2025 frame the typical range for FCF Margin.
- Across the five-year window, FCF Margin sank 5618 bps in 2024 and soared 5851 bps in 2025, its largest moves.
- Tracing CPIX's FCF Margin over 5 years: stood at 41.56% in 2022, then plunged by 74 bps to 10.6% in 2023, then soared by 72 bps to 18.23% in 2024, then slumped by 100 bps to 0.02% in 2025, then surged by 19066 bps to 4.24% in 2026.
- Business Quant data shows CPIX's FCF Margin at 4.24% in Q1 2026, 0.02% in Q4 2025, and 1.97% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -5.22% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 12.86% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5.35% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 46.54% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 9.93% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 17.73% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | -2.77% |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | 4.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.24% |
| Dec 31, 2025 | 0.02% |
| Sep 30, 2025 | 1.97% |
| Jun 30, 2025 | 7.54% |
| Mar 31, 2025 | 32.88% |
| Dec 31, 2024 | 18.23% |
| Sep 30, 2024 | 5.06% |
| Jun 30, 2024 | -8.76% |
| Mar 31, 2024 | -25.63% |
| Dec 31, 2023 | 10.60% |
| Sep 30, 2023 | 11.73% |
| Jun 30, 2023 | 47.42% |
| Mar 31, 2023 | -16.54% |
| Dec 31, 2022 | 41.56% |
| Sep 30, 2022 | 22.29% |
| Jun 30, 2022 | 21.30% |
| Mar 31, 2022 | -1.59% |
| Dec 31, 2021 | 41.37% |
| Sep 30, 2021 | -20.48% |
| Jun 30, 2021 | 29.64% |